Additionally, REV announces a concurrent non-brokered private placement for gross proceeds of up to $2.5 million pursuant to the listed issuer financing exemption (the "LIFE Offering"), at a price of $0.40 per share. No warrants are being issued in connection with either financing. Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106, Prospectus Exemptions, the LIFE Offering is being made to purchasers resident in Canada, excluding Québec, pursuant to the listed issuer financing exemption under Part 5A thereof. The Company will issue up to a maximum of 6,250,000 shares if the LIFE Offering is fully sold, for a combined maximum gross proceeds of $5.5 million when aggregated with the fully spoken Private Placement, which involves new strategic investors.
Securities issued under the LIFE Offering will not be subject to a statutory hold period in accordance with applicable Canadian securities laws. An offering document related to the LIFE Offering will be filed under the Company's profile on SEDAR+ and made available on the Company's website. Prospective investors should read the offering document before making an investment decision. The Private Placement and the LIFE Offering are subject to the approval of the TSX Venture Exchange and other applicable regulatory approvals and are expected to close on or around January 21, 2026.
In connection with the Private ...